Sudeep Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

SUDEEPPHRM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+3.3%1-day move

₹610.00

prior close

₹600.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.7+1.0+1.0+1.3+3.3+3.8+6.3+8.0+8.7+13.1+10.2+3.9+34.3+38.8

Up moveDown movePending

AI summary

Sudeep Pharma Limited has submitted a quarterly compliance certificate under SEBI's Regulation 74(5) for the quarter ended 31st March 2026. The certificate was issued by the company's Registrar and Share Transfer Agent, MUFG Intime India Private Limited (formerly Link Intime). MUFG Intime confirmed that during the quarter, no demat requests were received for processing because all shares of Sudeep Pharma are already held entirely in electronic (demat) form. The letter was filed with both NSE (Symbol: SUDEEPPHRM) and BSE (Code: 544619) on 10th April 2026 and signed by the Company Secretary, Dimple Mehta.

Likely market impact

This is a routine regulatory compliance filing with no material impact on shareholders or the stock price. It simply confirms that 100% of the company's shares are already in dematerialized form, reflecting good corporate housekeeping.